Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a modified vaccinia Ankara vaccine using three immunization schedules and two modes of delivery: A randomized clinical non-inferiority trial

Published:2017-03 Issue:13 Volume:35 Page:1675-1682
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jackson Lisa A.,Frey Sharon E.,El Sahly Hana M.,Mulligan Mark J.,Winokur Patricia L.,Kotloff Karen L.,Campbell James D.,Atmar Robert L.,Graham Irene,Anderson Evan J.,Anderson Edwin L.,Patel Shital M.,Fields Colin,Keitel Wendy,Rouphael Nadine,Hill Heather,Goll Johannes B.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference21 articles.

1. Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense;Henderson;JAMA,1999

2. Clinical guidance for smallpox vaccine use in a postevent vaccination program;Petersen;MMWR Recomm Rep,2015

3. Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine;Vollmar;Vaccine,2006

4. IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine;Kennedy;Expert Rev Vacc,2009

5. A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18–40 year old subjects with diagnosed atopic dermatitis;Greenberg;PLoS ONE,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predicting vaccine effectiveness for mpox;Nature Communications;2024-05-08

2. A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered With and Without AS03 Adjuvant in Healthy US Adults;Clinical Infectious Diseases;2024-03-27

3. Predicting vaccine effectiveness in Mpox;2023-11-24

4. Immunogenicity and Safety of Modified Vaccinia Ankara (MVA) Vaccine—A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2023-08-24

5. The Global Monkeypox (Mpox) Outbreak: A Comprehensive Review;Vaccines;2023-06-12